This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Syringes and vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered to healthcare workers at a drive-up vaccination site in Reno, Nev., on Dec. 17, 2020. Patrick T. Fallon/AFP via Getty Images
New South Wales (NSW) has opened a $96 million RNA research and pilot manufacturing facility at Macquarie University, a move aimed at strengthening Australia’s ability to develop vaccines and advanced therapies locally.
The new hub will produce messenger RNA (mRNA), synthetic RNA, lipid nanoparticles, and plasmid DNA on a small scale.
Monica O’Shea is a reporter based in Australia. She previously worked as a reporter for Motley Fool Australia, Daily Mail Australia, and Fairfax Regional Media. She can be reached at monica.o'[email protected]
